For more information about our Oncology Research
services, visit our website Veeda Oncology
Veeda Oncology is a vibrant Anglo/India CRO which brings together 20 years of clinical research expertise with the intellectual ability and tireless work ethic of the East. From First-in-Man studies to large scale Bioequivalence/Bioavailability comparator studies Veeda Clinical Research offers a fully integrated package to meet your early clinical development needs.
We provide phase 1 and phase II clinical trials and deliver cost effective research solutions for biotechnology oncology and pharmaceutical oncology. Veeda CR can take your compound from pre-clinical development to proof of concept in the most timely, cost effective manner.
Veeda Oncology is part of the Veeda Group that includes Veeda Clinical Research, which is a leading CRO specializing in the early oncology research, clinical development of drugs with state of the art clinical pharmacology units in the UK, Europe and India, fully accredited GLP Laboratories and an established Biometrics team in Belgium and India.
About Veeda:
Veeda Oncology is a vibrant Anglo/India CRO which brings together 20 years of clinical research expertise with the intellectual ability and tireless work ethic of the East. From First-in-Man studies to large scale Bioequivalence/Bioavailability comparator studies Veeda Clinical Research offers a fully integrated package to meet your early clinical development needs.
With state-of-the-art phase I facilities in Plymouth in the UK, Ahmadabad in India and Görlitz in Germany, fully accredited GLP laboratories, an established biometrics team in Belgium and India and a respected pre-clinical partner, Veeda CR can take your compound from pre-clinical development to proof of concept in the most timely, cost effective manner. For those clients unfamiliar with the benefits of outsourcing to India, or for those who choose to strategically spread their programs of work between two continents, Veeda CR can deliver significant cost savings combined with the complete reassurance of a UK project management service.
- Related Videos
- Related Articles
- Ask / Related Q&A
- Oncology Clinical Research and Trials for Biotechnology and Pharmaceutical Industries
- Medpace Inc. Expands Therapeutic Capabilities With the Acquisition of Pharma Brains AG, a European CRO With Global Experience in Oncology Drug Develop
- Primer on Clinical Research in India
- Bharatbook.com: Clinical Investigator Compensation by Therapeutic Area
- Viriom Selects ChemDiv to Develop HIV Program
- The Importance of Strong Study Feasibility on Patient Enrollment in India
- India: Attractive Market for Biopharmaceutical Companies Looking to Accelerate Their Clinical Trials
- First Survey Made Public on the Understanding and Experiences of Clinical Research Volunteers in India
How to survive cancer by making simple lifestyle changes
By: Alan Wighton | 08/12/2009The way to survive cancer is to treat the root cause or causes of the problem rather than just treating the obvious immediate symptoms which is the growths. Treating only symptoms may simple cover up the real underlying problem and make it worse so that it reappears later as something much more serious.
Chinese Antitumor Drug Market Scale Will Reach RMB 42 Billion (USD 6.16 Billion) in 2010
By: Alice Chen | 08/12/2009The acceleration of aging, urbanization and industrialization is the main cause for the rise of Chinese cancer incidence rate.
Water Purifiers - Cancer and the Case Against Chlorine
By: Lauren Casey | 07/12/2009Water purification through chlorine disinfection began in the United States in the late 1800s. It is only considered a water purifier because it kills some microscopic bacteria and other living organisms, while preventing the growth of algae.
Men and Breast Cancer
By: Ken Tetzolt | 07/12/2009The men of any age may develop breast cancer, but is usually detected in men between 45 and 65 years of age. Breast cancer found in men is less than 1% of all cases of breast cancer.
General Side Effects - Breast Enlargement and Natural Breast Enlargement Treatment
By: hardeepsingh | 06/12/2009For the best part of public, manage with pressure and awfully distressing or shocking actions or warfare is dealt with, with relation easiness. Admitting those in this better arrange touch the demolish personal property of pressure, distressing procedures.
Cancer Risk Reduction Linked to Sleep and Exercise
By: Aviisha Staff | 05/12/2009Regular exercise can lower the risk of developing cancerous disease, according to the American Association for Cancer Research. When exercise is combined with a quality sleeping regime, this risk can be reduced even further. To avoid serious diseases such as heart disease; Diabetes and stroke, it is imperative to combine a good exercise program with a beneficial sleeping routine.
Obesity Causing More than 100,000 New Cancer Cases Every Year
By: Aviisha Staff | 04/12/2009The links between cancer and being overweight have been well publicised for many years but now it is estimated that 100,000 new cases of cancer that are appearing each year might be directly linked with being obese and leading a sedentary life.
Ovarian Cancer Risk and Breast Cancer
By: Alex White | 03/12/2009Women who have developed breast cancer or who has a family history of the disease are advised to also watch out for signs of ovarian cancer.